Switching of the c-Myc protein degradation pathway depending on the PP2A-B55α complex levels
Abstract
The transcription factor c-Myc is a master oncoprotein that regulates over 15% of all genes. Protein phosphatase 2A (PP2A), a crucial tumor suppressor, destabilizes c-Myc protein. Classically, PP2A-mediated dephosphorylation of Ser62 followed by Thr58 phosphorylation was thought to promote ubiquitination of c-Myc by the E3 ligase F-box and WD repeat domain containing 7 (FBXW7). However, recent evidence indicates that FBXW7 preferentially recognizes c-Myc when both Thr58 and Ser62 are phosphorylated, leaving the mechanism underlying PP2A-induced c-Myc degradation unsolved. Here, we demonstrate that the PP2A-B55α complex, which directly dephosphorylates c-Myc at Thr58, regulates two distinct degradation pathways in a biphasic manner: B55α suppression increases Thr58 phosphorylation and enhances FBXW7-dependent degradation, whereas B55α overexpression promotes Thr58-independent, ubiquitin-protein ligase E3 component N-recognin 5 (UBR5)-mediated degradation. We further show that the PP2A-B55α complex binds and dephosphorylates UBR5. In contrast, B55δ, which belongs to the same B55 family and shares a common core structure, exhibits weaker UBR5 binding affinity and fails to induce c-Myc degradation. Our findings identify PP2A-B55α as a context-dependent molecular switch for c-Myc degradation and provide a unified framework that resolves the paradox linking PP2A activation to c-Myc destabilization.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (11)
Sana Ando
Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University
Shunta Ikeda
Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University
Keiko Tanaka
Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University
Yuri Tomabechi
Laboratory for Protein Functional and Structural Biology, RIKEN Center for Integrative Medical Sciences
Atsushi Yamagata
Mikako Shirouzu
Ryouichi Tsunedomi
Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine
Hiroaki Nagano
Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine
Shunya Tsuji
Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University
Koichi Sato
Takashi Ohama
Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University